No-reflow protection and long-term efficacy for acute myocardial infarction with Tongxinluo: a randomized double-blind placebo-controlled multicenter clinical trial (ENLEAT Trial). - Concepedia

Concepedia

Publication | Closed Access

No-reflow protection and long-term efficacy for acute myocardial infarction with Tongxinluo: a randomized double-blind placebo-controlled multicenter clinical trial (ENLEAT Trial).

50

Citations

0

References

2010

Year

Haitao Zhang, Zhenhua Jia, Jian Zhang, Zan-kai Ye, Wei-xian Yang, Yueqin Tian, Xuan Jia, Wei Li, Wu Yi-ling, Yuejin Yang

Abstract

Tongxinluo as a kind of traditional Chinese medicine could reduce myocardial no-reflow and infarction area significantly after emergency PCI for STEMI with conventional medicine therapy.